ArticleBMC geriatrics2026
SARC-F and six modified versions: prognostic role for prolonged hospital stay and 1-year mortality in older inpatients.
Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND &
aimsThe Strength, Assistance with Walking, Rising from a Chair, and Falls (SARC-F) questionnaire was proposed to screen sarcopenia. However, its limited sensitivity may compromise its prognostic value. Since its introduction, several adapted SARC-F-based approaches have been proposed, although their ability to predict clinical outcomes among older hospitalized individuals remains underexplored. This study aimed to investigate the prognostic value of SARC-F and six modified versions in a cohort of hospitalized individuals.
methodsCohort study with prospective data collection. Older adults (N = 236, 69.8 ± 7.5 years old) hospitalized in medical or surgical wards were included. Outcomes of interest were 1-year mortality and prolonged length of hospital stay (LOS). The original SARC-F was applied. Additional adapted approaches were explored: (1) SARC-CalF (including calf circumference, CC); (2)
resultsSARC-F EBM was the approach identifying the lowest rate of suggestive signs of sarcopenia (25.9%), while
conclusionOur study demonstrates that all SARC-F-based approaches are linked to prolonged LOS, and almost all approaches were also linked to 1-year mortality. We also introduce the novel
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.